Product Information
VIOKACE 20,880-78,300 UNITS TB is a brand product labeled by Aimmune Therapeutics, Inc., priced at $8.2125 per EA under NDC 73562020810. Its NADAC has been published 97 times since Aug 21, 2024.
Strength
78300; 20880; 78300 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Aimmune Therapeutics, Inc.NDC
73562020810
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
12/31/2025
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022542On Market Since
3/1/2021
Price Statistics
The NADAC for VIOKACE 20,880-78,300 UNITS TB has been published 97 times since Aug 21, 2024, and over the history we have for it it has risen 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.2125 per EA |
|---|---|
| All-time high | $8.2125 (Jun 24, 2026) |
| All-time low | $7.9288 (Nov 20, 2024) |
| 52-week high | $8.2125 |
| 52-week low | $7.9711 |
| Median price | $7.9733 |
| Average price | $8.0249 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 97 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Pancrelipase market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VIOKACE 20,880-78,300 UNITS TB?
The current National Average Drug Acquisition Cost (NADAC) for VIOKACE 20,880-78,300 UNITS TB, manufactured by Aimmune Therapeutics, Inc., is $8.2125 per EA (NDC 73562020810), effective Jun 24, 2026.
How has the price of VIOKACE 20,880-78,300 UNITS TB changed over time?
Over the history we have for it, the NADAC for VIOKACE 20,880-78,300 UNITS TB has risen 3.4%. It has been tracked across 97 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for VIOKACE 20,880-78,300 UNITS TB?
Since Aug 21, 2024, the NADAC for VIOKACE 20,880-78,300 UNITS TB has ranged from a low of $7.9288 (Nov 20, 2024) to a high of $8.2125 (Jun 24, 2026), with a median of $7.9733 per EA.
Are there cheaper alternatives to VIOKACE 20,880-78,300 UNITS TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VIOKACE 20,880-78,300 UNITS TB, so no direct lower-cost alternative is listed.
Who manufactures VIOKACE 20,880-78,300 UNITS TB?
VIOKACE 20,880-78,300 UNITS TB (NDC 73562020810) is labeled by Aimmune Therapeutics, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification